Ignite Creation Date:
2025-12-24 @ 9:06 PM
Ignite Modification Date:
2026-03-14 @ 4:58 PM
Study NCT ID:
NCT02203604
Status:
TERMINATED
Last Update Posted:
2023-07-18
First Post:
2014-07-28
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
High-Dose Aldesleukin and Ipilimumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed By Surgery
Sponsor:
CINJRegulatory
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-11-26
Start Date Type:
ACTUAL
Primary Completion Date:
2020-01-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-01-27
Completion Date Type:
ACTUAL
First Submit Date:
2014-07-28
First Submit QC Date:
None
Study First Post Date:
2014-07-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-09-01
Results First Submit QC Date:
None
Results First Post Date:
2023-06-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-07-03
Last Update Post Date:
2023-07-18
Last Update Post Date Type:
ACTUAL